| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |